Vanessa Rivera-Amill to Drug Resistance, Viral
This is a "connection" page, showing publications Vanessa Rivera-Amill has written about Drug Resistance, Viral.
Connection Strength
1.150
-
L?pez P, De Jes?s O, Yamamura Y, Rodr?guez N, Arias A, S?nchez R, Rodr?guez Y, Tamayo-Agrait V, Cuevas W, Rivera-Amill V. Molecular Epidemiology of HIV-1 Virus in Puerto Rico: Novel Cases of HIV-1 Subtype C, D, and CRF-24BG. AIDS Res Hum Retroviruses. 2018 06; 34(6):507-516.
Score: 0.623
-
L?pez P, Tirado G, Arias A, S?nchez R, Rodr?guez-L?pez ER, Rivera-Amill V. Short Communication: Integrase Strand Transfer Inhibitors Drug Resistance Mutations in Puerto Rico HIV-Positive Individuals. Int J Environ Res Public Health. 2021 03 08; 18(5).
Score: 0.189
-
Parkin NT, Avila-Rios S, Bibby DF, Brumme CJ, Eshleman SH, Harrigan PR, Howison M, Hunt G, Ji H, Kantor R, Ledwaba J, Lee ER, Mat?as-Florentino M, Mbisa JL, Noguera-Julian M, Paredes R, Rivera-Amill V, Swanstrom R, Zaccaro DJ, Zhang Y, Zhou S, Jennings C. Multi-Laboratory Comparison of Next-Generation to Sanger-Based Sequencing for HIV-1 Drug Resistance Genotyping. Viruses. 2020 06 27; 12(7).
Score: 0.180
-
Arias A, L?pez P, S?nchez R, Yamamura Y, Rivera-Amill V. Sanger and Next Generation Sequencing Approaches to Evaluate HIV-1 Virus in Blood Compartments. Int J Environ Res Public Health. 2018 08 09; 15(8).
Score: 0.158